Biomedix Incubator Valuation
| BMDX Stock | ILS 14,890 490.00 3.40% |
At this time, the firm appears to be overvalued. Biomedix Incubator shows a prevailing Real Value of S12954.3 per share. The current price of the firm is S14890.0. Our model approximates the value of Biomedix Incubator from analyzing the firm fundamentals such as Price To Earning of (545.45) X, current valuation of 14.72 M, and Return On Equity of -21.76 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Biomedix Incubator's price fluctuation is very steady at this time. Calculation of the real value of Biomedix Incubator is based on 3 months time horizon. Increasing Biomedix Incubator's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Biomedix Incubator is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biomedix Stock. However, Biomedix Incubator's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 14890.0 | Real 12954.3 | Hype 14890.0 | Naive 13630.7 |
The real value of Biomedix Stock, also known as its intrinsic value, is the underlying worth of Biomedix Incubator Company, which is reflected in its stock price. It is based on Biomedix Incubator's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Biomedix Incubator's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Biomedix Incubator helps investors to forecast how Biomedix stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biomedix Incubator more accurately as focusing exclusively on Biomedix Incubator's fundamentals will not take into account other important factors: Biomedix Incubator Total Value Analysis
Biomedix Incubator is currently forecasted to have takeover price of 14.72 M with market capitalization of 37.28 M, debt of 0, and cash on hands of 5.71 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Biomedix Incubator fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
14.72 M | 37.28 M | 0 | 5.71 M |
Biomedix Incubator Investor Information
The company recorded a loss per share of 1.1. Biomedix Incubator had not issued any dividends in recent years. The entity had a split on the 22nd of October 2017. Based on the analysis of Biomedix Incubator's profitability, liquidity, and operating efficiency, Biomedix Incubator is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Biomedix Incubator Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Biomedix Incubator has an asset utilization ratio of 0.0222 percent. This suggests that the Company is making S2.22E-4 for each dollar of assets. An increasing asset utilization means that Biomedix Incubator is more efficient with each dollar of assets it utilizes for everyday operations.Biomedix Incubator Profitability Analysis
The company reported the revenue of 2 K. Net Loss for the year was (1.36 M) with loss before overhead, payroll, taxes, and interest of (39 K).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Biomedix Incubator's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Biomedix Incubator and how it compares across the competition.
About Biomedix Incubator Valuation
The stock valuation mechanism determines Biomedix Incubator's current worth on a weekly basis. Our valuation model uses a comparative analysis of Biomedix Incubator. We calculate exposure to Biomedix Incubator's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Biomedix Incubator's related companies.Biomedix Incubator Ltd is a venture capital firm and accelerator specializing in start-up and incubation investments. Biomedix Incubator Ltd. was founded in 2000 and is based in Ramat Gan, Israel with an additional office in New York, New York. Biomedix Incubator is traded on Tel Aviv Stock Exchange in Israel.
8 Steps to conduct Biomedix Incubator's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Biomedix Incubator's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Biomedix Incubator's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Biomedix Incubator's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Biomedix Incubator's revenue streams: Identify Biomedix Incubator's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Biomedix Incubator's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Biomedix Incubator's growth potential: Evaluate Biomedix Incubator's management, business model, and growth potential.
- Determine Biomedix Incubator's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Biomedix Incubator's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Biomedix Stock analysis
When running Biomedix Incubator's price analysis, check to measure Biomedix Incubator's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomedix Incubator is operating at the current time. Most of Biomedix Incubator's value examination focuses on studying past and present price action to predict the probability of Biomedix Incubator's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomedix Incubator's price. Additionally, you may evaluate how the addition of Biomedix Incubator to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |